GLAUCOMA
CARE REDEFINED
Advancing excellence in glaucoma surgical care through Next-Generation Glaucoma Surgery technology, ensuring exceptional efficacy, safety, and precision for superior patient outcomes.
Home 2
Next-Generation Glaucoma Surgery
Technology Revolutionizing Glaucoma Care with PLU Ophthalmic
THE CHALLENGE
Glaucoma is the second leading cause of blindness worldwide, imposing significant economic costs, especially in the United States.
PREVALENCE:
80,000
People affected globally
IMPACT:
22 Mil
People worldwide are at risk of irreversible blindness due to open angle glaucoma.
3 Mil
People in the US
28 %
Growth rate per decade
ECONOMIC COST:
$2.8 Mil
Direct cost to the US annually (2022)
44,037
Productivity losses per year, per affected individual
$12 Bil
Would be the projected cost by 2032 and $17.3 billion by 2050
THE SYMPTOMS
Silent thief of sight
Glaucoma is often called the “silent thief of sight” because it usually has no symptoms until significant vision loss has occurred. However, there are some signs and symptoms to watch for, including:
Gradual Loss of Peripheral Vision
Often the first noticeable symptom, especially in open-angle glaucoma
Tunnel Vision
In the advanced stages of the disease
Severe Eye Pain
Associated with acute angle-closure glaucoma
Nausea and Vomiting
Accompanying severe eye pain
Blurred Vision
Especially during a sudden onset
Halos Around Lights
Seeing rainbow-colored rings around lights
Redness in the Eye
This can be a sign of glaucoma
Headaches
Often in conjunction with eye pain
Early stages
In early stages there are few to no symptoms present
No Early Detection
There is no single definitive test for diagnosing glaucoma, requiring a combination of assessments to detect the condition accurately
Not Knowing
Half of the people with glaucoma are not aware that they have it
Current Glaucoma Surgical Treatments
Current surgical options force surgeons to choose between efficacy and safety, with no ideal treatment available.
Traditional Intervention:
Trabeculectomy
Trabeculectomy is a highly effective procedure for glaucoma, but it carries significant risks and potential complications. Risks and complications for traditional trabeculectomy:
- Intra-operative Complications: Issues that arise during the surgery itself, increasing the complexity and risk of the procedure.
- Post-operative Complications: Problems that occur after surgery, potentially leading to prolonged recovery times or additional treatments.
- Failure Risk: The possibility that the treatment may not achieve the desired outcome, necessitating further interventions.>/span>
Minimally Invasive Glaucoma Surgery (MIGS)
Minimally Invasive Glaucoma Surgery (MIGS) aims to provide a high safety profile; however, it offers less than ideal efficacy. Types of MIGS include stents, microshunts, canaloplasties, and goniotomy. The current MIGS changes are:
- Limited Long-Term Efficacy: MIGS procedures often result in less IOP reduction, making them insufficient for patients with advanced glaucoma.
- Significant Learning Curve: Significant Learning Curve: These procedures are technically challenging, and their success is highly dependent on the surgeon’s skill and experience.
- High Cost: The high cost includes the expense of the devices themselves and the need for specialized training and equipment.
The Future of Glaucoma Treatment
Our innovative approach eliminates the need for compromise, offering a solution that combines high efficacy with superior safety, setting a new standard in glaucoma care.
01
Superior outcomes without the current trade-off between efficacy and safety.
02
Minimally invasive, implant-free glaucoma surgery utilizing precise micro-excision technology.
03
Improved productivity with shorter surgical times, superior ease of use, and minimal learning curve, leading to higher OR throughput and reduced post-operative patient management.